CLDN7 and non-small cell lung carcinoma: For instance, Claudin1 has been shown to induce drug resistance mediated by autophagy in non-small cell lung cancer by ULK1 phosphorylation [29], and it acts as an autophagy stimulant, accelerating the degradation of SQSTM1/p62 [30].